Advertisement

Topics

FDA approval in hand, Sarepta plans for future studies

10:32 EDT 22 Sep 2016 | BioPharmaDive

The Cambridge-based biotech announced plans for a proposed $225 million stock offering to fund further clinical testing on and production of eteplirsen. 

Original Article: FDA approval in hand, Sarepta plans for future studies

NEXT ARTICLE

More From BioPortfolio on "FDA approval in hand, Sarepta plans for future studies"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...